These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8880289)

  • 1. Pharmacokinetics of theophylline in obesity.
    Zahorska-Markiewicz B; Waluga M; Zieliñski M; Klin M
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):393-5. PubMed ID: 8880289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of sustained-release in theophylline (Slobid, Theolong, Theodur) by pharmacokinetics].
    Kotake T; Mihara M; Shibakawa M; Asamoto
    Arerugi; 1997 Apr; 46(4):370-5. PubMed ID: 9154697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
    Okuma M; Iikura Y
    Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of sustained-release in theophylline (Slobid, Theolong, Theodur) by pharmacokinetics].
    Kotake T; Mihara M; Shibakawa M; Asamoto H
    Nihon Rinsho; 1996 Nov; 54(11):3119-24. PubMed ID: 8950965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline loading dose in obese patients.
    Visram N; Friesen EG; Jamali F
    Clin Pharm; 1987 Mar; 6(3):188-9. PubMed ID: 3665374
    [No Abstract]   [Full Text] [Related]  

  • 8. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hypoalbuminemia on the disposition of theophylline. Comparative study with Sprague-Dawley rats and a mutant Sprague-Dawley hyperlipidemic strain with hypoalbuminemia.
    Nakura H; Tateishi T; Watanabe M; Asoh M; Tanaka M; Kumai T; Kobayashi S
    Drug Metab Dispos; 1998 Jun; 26(6):595-7. PubMed ID: 9616197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline clearance in undernourished asthma patients.
    Raj NS; Misra A; Guleria R; Pande JN
    Indian J Chest Dis Allied Sci; 1998; 40(3):175-8. PubMed ID: 9919837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of obesity on clinical presentation and response to treatment in asthma.
    Dixon AE; Shade DM; Cohen RI; Skloot GS; Holbrook JT; Smith LJ; Lima JJ; Allayee H; Irvin CG; Wise RA;
    J Asthma; 2006 Sep; 43(7):553-8. PubMed ID: 16939998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacokinetic interactions between cilomilast and theophylline or smoking in healthy volunteers.
    Murdoch RD; Zussman B; Schofield JP; Webber DM
    J Clin Pharmacol; 2004 Sep; 44(9):1046-53. PubMed ID: 15317832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of weight loss resulting from a combined low-fat diet/exercise regimen on low-density lipoprotein particle size and distribution in obese women.
    Varady KA; Lamarche B; Santosa S; Demonty I; Charest A; Jones PJ
    Metabolism; 2006 Oct; 55(10):1302-7. PubMed ID: 16979399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-course changes in macronutrient metabolism induced by a nutritionally balanced low-calorie diet in obese women.
    Labayen I; Diez N; Parra MD; Gónzalez A; Martínez JA
    Int J Food Sci Nutr; 2004 Feb; 55(1):27-35. PubMed ID: 14630589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of protein vs. carbohydrate-rich diets on fuel utilisation in obese women during weight loss.
    Labayen I; Díez N; González A; Parra D; Martínez JA
    Forum Nutr; 2003; 56():168-70. PubMed ID: 15806847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of theophylline in preterm neonates during the first month of life.
    Islam SI; Ali AS; Sheikh AA; Fida NM
    Saudi Med J; 2004 Apr; 25(4):459-65. PubMed ID: 15083216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic modeling of theophylline in patients with different degrees of airway obstruction.
    Flores-Murrieta FJ; Mercado DE; Rodríguez-Silverio J; Chapela R
    Proc West Pharmacol Soc; 1999; 42():3-4. PubMed ID: 10697671
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
    Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of theophylline metabolites in 8 Chinese patients.
    Cao W; Zhuo HT; Chen G; Ling SS
    Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):437-9. PubMed ID: 10375804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of bamifylline during chronic therapy.
    Segre G; Cerretani D; Moltoni L; Urso R; Fusillo M
    Arzneimittelforschung; 1990 Apr; 40(4):450-2. PubMed ID: 2357245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.